Fig. 2From: Systemic inflammation and insulin resistance-related indicator predicts poor outcome in patients with cancer cachexiaThe 1-, 3-, and 5-year prognostic ROC and calibration curves of CTI in the different cohorts of patients with cancer cachexia. A-C 1-, 3-, and 5-year prognostic ROC curves, A Total cohort, B Internal test cohort, C External validation cohort; D-F 1-, 3-, and 5-year prognostic calibration curves, D Total cohort, E Internal test cohort, F External validation cohort. Notes: CTI, C-reactive protein-triglyceride glucose index; ROC, receiver operating characteristicBack to article page